UTEC — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

RegCellregcellbio.comMar 2025

RegCell Biosciences is a biotechnology company developing regenerative cell therapies, leveraging expertise in cell and gene therapy, manufacturing, and immunology to advance therapeutic treatments.

BiotechDeep TechMedical Devices

Michael McCullar, PhD(Chief Executive Officer)James Ahlers(Chief Financial Officer)Marty Giedlin, PhD(Chief Technology Officer)Tony Hurley(Chief Technical Operations Officer)Steve Kanner, PhD(Chief Scientific Officer)

Co-investorsFast Track Initiative Global Brain Kyoto University Innovation Capital Mitsubishi UFJ Capital OSAKA University Venture Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.